Mutant p53 Drives Pancreatic Cancer Metastasis through Cell-Autonomous PDGF Receptor β Signaling

Weissmueller, Susann, Manchado, Eusebio, Saborowski, Michael, Morris, John P., Wagenblast, Elvin, Davis, Carrie A., Moon, Sung-Hwan, Pfister, Neil T., Tschaharganeh, Darjus F., Kitzing, Thomas, Aust, Daniela, Markert, Elke K., Wu, Jianmin, Grimmond, Sean M., Pilarsky, Christian, Prives, Carol, Biankin, Andrew V., Lowe, Scott W.·2014·Cell
DOI 10.1016/j.cell.2014.01.066

Cited by (470)

Items 401–470 of 470

  1. VEGFR and PDGFR Targeting in Pancreatic Cancer
    Gowru Srivani, Shipra Reddy Bethi, Sheik Aliya, Afroz Alam, Ganji Purnachandra Nagaraju · 2018 · Springer eBooks
  2. Pancreatic Carcinogenesis
    Valentin Taucher, Johannes Haybaeck · 2017 · Springer eBooks
  3. Mouse Models of Pancreatic Exocrine Cancer
    Pedro Antonio Pérez-Mancera · 2018 · Springer eBooks
  4. Exploration of the System-Level Mechanisms of the Herbal Drug FDY003 for Pancreatic Cancer Treatment: A Network Pharmacological Investigation
    Ho-Sung Lee, In-Hee Lee, Kyungrae Kang, Sang‐In Park, Minho Jung, Seung Gu Yang, Tae-Wook Kwon, Dae-Yeon Lee · 2022 · Evidence-based Complementary and Alternative Medicine
  5. Molecular biology of pancreatic ductal adenocarcinoma
    Stacey J. Coleman, Andrew D. Rhim · 2014 · Current Opinion in Gastroenterology
  6. Profile of Scott W. Lowe
    Sandeep Ravindran · 2018 · Proceedings of the National Academy of Sciences
  7. Novel Molecular Targets and Mechanisms Involved in the Invasion and Metastasis of Pancreatic Cancer
    Ziyi Li, Weidong Li, Yuqi Dong, Xueying Sun · 2019 · Clinical Cancer Drugs
  8. PDGF
    Nahyun Choi, Jung-Hun Moon, Jong‐Hyuk Sung · 2016 · Springer eBooks
  9. Caffeic acid, a dietary polyphenol pre-sensitizes PDAC to chemotherapeutic drug
    Shruti Gupta, Harshita Tak, Khushhal Rathore, Hemanth Naick Banavath, Kiran Kumar Tejavath · 2023 · Research Square
  10. Reply to ‘Heterogeneity of TP53 mutations necessitates differentiation with p53-rescue therapies’
    Sylvain Peuget, Galina Selivanova · 2025 · Nature reviews. Cancer
  11. State of cancer in Bangladesh: An introductory review on microbiological perspective
    Saurab Kishore Munshi, Ifra Tun Nur, Rashed Noor · 2016 · Stamford Journal of Microbiology
  12. MEK inhibition in pancreas cancer
    Francesca Vena · 2016 · UCL Discovery (University College London)
  13. Characterization and functional analysis of mutant p53 secretome in human cancer
    Reshma Shakya · 2016 · Adelaide Research & Scholarship (AR&S) (University of Adelaide)
  14. Mouse Models of Pancreatic Exocrine Cancer
    Pedro Antonio Pérez-Mancera · 2017 · Springer eBooks
  15. Gain-of-function and dominant-negative effects of distinct p53 mutations in lung tumours
    Frances K. Turrell · 2018 · Apollo (University of Cambridge)
  16. Cooperating Oncogenic Alterations in Aggressive Pten-Deficient Breast Cancer
    Sharon Wang · 2017 · TSpace (University of Toronto)
  17. Therapeutic Potential of Tumor Suppressors in Treating Breast Cancer
    Kunnath AP · 2018 · International Journal of Cancer Studies & Research
  18. p53-Hsp90 Axis in Human Cancer
    Amr M. Ghaleb, Natalia D. Marchenko · 2019 · Heat shock proteins
  19. Subtypes of Pancreatic Adenocarcinoma
    Luisa Ingenhoff, Lena Häberle, Iréne Esposito · 2020 · Molecular and translational medicine
  20. Generation of a New Model for RB1-deficient Pineoblastoma and Lysosome-based Therapy
    Eu Ddeum Chung · 2019 · TSpace (University of Toronto)
  21. Peer Review #3 of "Tumor-preventing activity of aspirin in multiple cancers based on bioinformatic analyses (v0.1)"
    2018 · PeerJ
  22. Peer Review #1 of "Tumor-preventing activity of aspirin in multiple cancers based on bioinformatic analyses (v0.2)"
    2018 · PeerJ
  23. Peer Review #4 of "Tumor-preventing activity of aspirin in multiple cancers based on bioinformatic analyses (v0.1)"
    2018 · PeerJ
  24. Peer Review #2 of "Tumor-preventing activity of aspirin in multiple cancers based on bioinformatic analyses (v0.1)"
    2018 · PeerJ
  25. Cell Cycle Machinery and Its Alterations in Pancreatic Cancer
    Yusuke Kojima, Reeja S. Maskey, Yuichi Machida · 2017 · Springer eBooks
  26. Peer Review #1 of "Tumor-preventing activity of aspirin in multiple cancers based on bioinformatic analyses (v0.1)"
    2018 · PeerJ
  27. Peer Review #3 of "Tumor-preventing activity of aspirin in multiple cancers based on bioinformatic analyses (v0.2)"
    2018 · PeerJ
  28. Introducing, OncoTarget
    Mikhail V. Blagosklonny, Andrei V. Gudkov · 2010 · Oncotarget
  29. PDGF
    Nahyun Choi, Jung-Hun Moon, Jong‐Hyuk Sung · 2017 · Springer eBooks
  30. A multigene circulating biomarker to predict the lack of FOLFIRINOX response after a single cycle in patients with pancreatic ductal adenocarcinoma (PDAC)
    Casper W.F. van Eijck, Willem de Koning, Fleur van der Sijde, Miranda Moskie, Bas Groot Koerkamp, Marjolein Y.V. Homs, Sjoerd H. van der Burg, Casper H.J. van Eijck, Dana A. M. Mustafa · 2022 · Research Square
  31. A Succinct Molecular Profile of High-Grade Ovarian Cancer
    Imam Malik Kabir, Abdulaziz Tahir Idris · 2022 · IntechOpen eBooks
  32. Data from HDAC2 Facilitates Pancreatic Cancer Metastasis
    Lukas Krauß, Bettina C. Urban, Sieglinde Hastreiter, Carolin Schneider, Patrick Wenzel, Zonera Hassan, Matthias Wirth, Katharina Lankes, Andrea Terrasi, Christine Klement et al. · 2023
  33. Chromosome 5
    Sayooj Madhusoodanan, Saurav Panicker, Satish Ramalingam · 2023 · BENTHAM SCIENCE PUBLISHERS eBooks
  34. Influence of long-term acid adaptation and acute microenvironmental pH changes on Pancreatic Ductal Adenocarcinoma (PDAC) development, progression and invasion
    Jakub Mitrega · 2023
  35. Macro understanding of the therapeutic role of phospholipase and their metabolites in pancreatic ductal and periampullary adenocarcinoma
    Nilabja Sikdar, Arunima Maiti, Subhankar Dey, Paromita Roy, Bitan Kumar Chattopadhyay · 2023 · Elsevier eBooks
  36. Kras loss of heterozygosity promotes MAPK dependent pancreatic ductal adenocarcinoma and induces therapeutic sensitivity
    Sigrid K. Fey, Arafath Kaja Najumudeen, Catriona A. Ford, Kathryn L. Gilroy, Rosanna Upstill‐Goddard, David Kuang-Fu Chang, William Clark, Colin Nixon, Simon T. Barry, Jennifer P. Morton et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  37. Expressional correlations between SERPINA6 and pancreatic ductal adenocarcinoma-linked genes
    Maxwell Selver, Lisa Tibbetts · 2021 · Journal of Emerging Investigators
  38. Additional file 1 of TP53 missense mutation reveals gain-of-function properties in small-sized KRAS transformed pancreatic ductal adenocarcinoma
    Yiran Zhou, Jiabin Jin, Yuchen Ji, Jiaqiang Zhang, Ningzhen Fu, Mengmin Chen, Jun Wang, Kai Qin, Jiang, Yu, Dongfeng Cheng et al. · 2023 · Figshare
  39. Additional file 2 of TP53 and TP53-associated genes are correlated with the prognosis of paediatric neuroblastoma
    Haiwei Wang, Xinrui Wang, Liangpu Xu, Ji Zhang · 2022 · Figshare
  40. Integrin factor (FAM27E3), as a metastatic marker of papillary thyroid carcinoma, through the p53 signaling pathway promoting lymph node metastasis
    Dong Zhang, Kai-fang Xiang, Chen-Chen Hong, Xiao-Ping Bao, Yan Fen Wu, Rui Wu · 2025 · Frontiers in Genetics
  41. Real-world evidence of chemotherapy effects in advanced pancreatic ductal adenocarcinoma: prognostic significance of TP53 status in gemcitabine plus nab-paclitaxel therapy
    M. Sugimori, Akane Hirotani, Hajime Yamazaki, Masanori Oshi, Keigo Kawashima, Hiromi Tsuchiya, Yu Kanemaru, Yoshimasa Suzuki, S. Onodera, Hiroto Miwa et al. · 2025 · ESMO Gastrointestinal Oncology
  42. Pancreatic Cancer and Benign Pancreatic Cystic Lesions: Differences in Cytokines, Growth Factors, and Immunological Markers Concentrations in Serum and Cystic Fluid
    Ewa Grudzińska, Paweł Szmigiel, Karolina Majewska, Sławomir Mrowiec, Zenon Paweł Czuba · 2025 · Cancers
  43. Hypoxia-induced metastatic heterogeneity in pancreatic cancer
    Pradeep Moon Gunasekaran, Qianqian Wang, Polina Guseva, Yoke‐Chen Chang, Rajika Chauhan, Alexander Kley, Mengdie Xu, Gene Lee, Gregory Marshall, Siddharth Ghosh Roy et al. · 2026 · Nature Communications
  44. Distinct functional heterogeneity of TP53 R175 mutations in platinum-resistant ovarian cancer: unveiling molecular mechanisms and therapeutic targets
    Yufeng Liu, Zhiguo Zheng, Maowei Ni, Shuyu Mao, Yue Xiao, Ye Zhao, Bing Tian, Liangyan Wang, Hong Xu, Yuejin Hua · 2025 · Cell Death and Disease
  45. RETRACTED: Ph-triazole as a therapeutic agent for pancreatic cancer: Synthesis, in silico, and in vitro evaluation
    Ningbo Zhang, Xingxing Li, Fangyuan Li, Jianjiang Jin, Ting Zheng, Li Zhou · 2025 · PLoS ONE · Retracted
  46. Additional file 5 of Mutant p53-ENTPD5 control of the calnexin/calreticulin cycle: a druggable target for inhibiting integrin-α5-driven metastasis
    Evangelos Pavlakis, Neumann, Michelle, Nastasja Merle, Ronja Wieboldt, Michael Wanzel, Viviane Ponath, Elke Pogge von Strandmann, Sabrina Elmshäuser, Thorsten Stiewe · 2023 · Figshare
  47. Additional file 2 of Mutant p53-ENTPD5 control of the calnexin/calreticulin cycle: a druggable target for inhibiting integrin-α5-driven metastasis
    Evangelos Pavlakis, Neumann, Michelle, Nastasja Merle, Ronja Wieboldt, Michael Wanzel, Viviane Ponath, Elke Pogge von Strandmann, Sabrina Elmshäuser, Thorsten Stiewe · 2023 · Figshare
  48. Additional file 5 of TP53 missense mutation reveals gain-of-function properties in small-sized KRAS transformed pancreatic ductal adenocarcinoma
    Zhou, Yiran, Jin, Jiabin, Yuchen Ji, Zhang, Jiaqiang, Ningzhen Fu, Chen, Mengmin, Wang, Jun, Kai Qin, Jiang, Yu, 程东峰 et al. · 2024 · Figshare
  49. Additional file 6 of Mutant p53-ENTPD5 control of the calnexin/calreticulin cycle: a druggable target for inhibiting integrin-α5-driven metastasis
    Evangelos Pavlakis, Neumann, Michelle, Nastasja Merle, Ronja Wieboldt, Michael Wanzel, Viviane Ponath, Elke Pogge von Strandmann, Sabrina Elmshäuser, Thorsten Stiewe · 2023 · Figshare
  50. Additional file 4 of Mutant p53-ENTPD5 control of the calnexin/calreticulin cycle: a druggable target for inhibiting integrin-α5-driven metastasis
    Evangelos Pavlakis, Neumann, Michelle, Nastasja Merle, Ronja Wieboldt, Michael Wanzel, Viviane Ponath, Elke Pogge von Strandmann, Sabrina Elmshäuser, Thorsten Stiewe · 2023 · Figshare
  51. Additional file 2 of TP53 missense mutation reveals gain-of-function properties in small-sized KRAS transformed pancreatic ductal adenocarcinoma
    Zhou, Yiran, Jin, Jiabin, Yuchen Ji, Zhang, Jiaqiang, Ningzhen Fu, Chen, Mengmin, Wang, Jun, Kai Qin, Jiang, Yu, 程东峰 et al. · 2024 · Figshare
  52. Additional file 1 of Mutant p53-ENTPD5 control of the calnexin/calreticulin cycle: a druggable target for inhibiting integrin-α5-driven metastasis
    Evangelos Pavlakis, Neumann, Michelle, Nastasja Merle, Ronja Wieboldt, Michael Wanzel, Viviane Ponath, Elke Pogge von Strandmann, Sabrina Elmshäuser, Thorsten Stiewe · 2023 · Figshare
  53. Additional file 1 of TP53 and TP53-associated genes are correlated with the prognosis of paediatric neuroblastoma
    Wang, Haiwei, Wang, Xinrui, Liangpu Xu, Ji Zhang · 2022 · Figshare
  54. Additional file 3 of Mutant p53-ENTPD5 control of the calnexin/calreticulin cycle: a druggable target for inhibiting integrin-α5-driven metastasis
    Evangelos Pavlakis, Neumann, Michelle, Nastasja Merle, Ronja Wieboldt, Michael Wanzel, Viviane Ponath, Elke Pogge von Strandmann, Sabrina Elmshäuser, Thorsten Stiewe · 2023 · Figshare
  55. Additional file 3 of TP53 missense mutation reveals gain-of-function properties in small-sized KRAS transformed pancreatic ductal adenocarcinoma
    Zhou, Yiran, Jin, Jiabin, Yuchen Ji, Zhang, Jiaqiang, Ningzhen Fu, Chen, Mengmin, Wang, Jun, Kai Qin, Jiang, Yu, 程东峰 et al. · 2024 · Figshare
  56. Additional file 7 of Mutant p53-ENTPD5 control of the calnexin/calreticulin cycle: a druggable target for inhibiting integrin-α5-driven metastasis
    Evangelos Pavlakis, Neumann, Michelle, Nastasja Merle, Ronja Wieboldt, Michael Wanzel, Viviane Ponath, Elke Pogge von Strandmann, Sabrina Elmshäuser, Thorsten Stiewe · 2023 · Figshare
  57. Additional file 4 of TP53 missense mutation reveals gain-of-function properties in small-sized KRAS transformed pancreatic ductal adenocarcinoma
    Zhou, Yiran, Jin, Jiabin, Yuchen Ji, Zhang, Jiaqiang, Ningzhen Fu, Chen, Mengmin, Wang, Jun, Kai Qin, Jiang, Yu, 程东峰 et al. · 2024 · Figshare
  58. Conséquences traductionnelles de la perte de 4E-BP1 dans l'adénocarcinome pancréatique
    David Müller · 2016 · theses.fr (ABES)
  59. Implication de la voie p53 dans les syndromes d'insuffisance médullaire
    Eléonore Toufektchan · 2018 · theses.fr (ABES)
  60. Glioblastoma resistance to temozolomide : implication of α5β1 integrin and p53 signalling pathways
    Saidu Sani · 2020 · theses.fr (ABES)
  61. Characterisation of SG33 Myxoma virus replication and oncolytic activity in pancreatic cancer models
    Lorraine Quillien · 2021 · theses.fr (ABES)
  62. Etude de l’influence du TGF-β sur les sous-populations de fibroblastes associés au cancer et leur implication pronostique dans les cancers du pancréas
    Angélique Vienot · 2021 · theses.fr (ABES)
  63. An integrative mutational and network analysis of pancreatic cancer reveals key genes, and signalling pathways
    Gowrang Kasaba Manjunath, Lasya Priya Kanchi, Tikam Chand Dakal, Abhijit Beura, Abhishek Kumar · 2026 · Functional & Integrative Genomics
  64. LFPM inhibition of RING1-mediated p53R175H degradation drives oncogenesis in p53R175H-mutant cancers
    Xingkai Li, Bing Wang, Zhen Wang, Yue Li, Yupei Li, Yushun Gao, Xianteng Wang · 2026 · Cell Death and Differentiation
  65. Physioxia Reprograms Glioblastoma Cells Enhancing Migration and Altering Therapeutic Sensitivity
    Natasha Hockaden, Elise O’Herron, Dylan Zhou, Nicholas F. Downing, Jacob Kurlander, Margaret Heffernan, Scott H. Cooper, Angela Mae Richardson · 2026 · Cancers
  66. Harnessing autophagy and its transcriptional regulation in tumorigenesis and neurodegeneration: Potential and existing therapeutic strategies
    Parul Suri, Abel B. Daartey, D M Isha Olive Khan, Naga Pradeep Rayana, Rameswari Chilamakuri, Deepika Godugu, Mahan Gholam Azad, Katelyn Louise Reeb, Des Raymond Richardson · 2026 · Pharmacological Reviews
  67. Network Pharmacology-Based Elucidation of Piperlongumine Action on Oncogenic Survival and Immune-Evasive Pathways in Pancreatic Cancer
    Imene Derardja, Redouane Rebai, Luc Jasmin, Abdennacer Boudah · 2026
  68. Structures and dynamics of the major G-quadruplex in the human PDGFR-β gene promoter: insights into vacancy G-quadruplex formation
    Yichen Han, Jonathan Dickerhoff, Danzhou Yang · 2026 · Nucleic Acids Research
  69. Metastatic pancreatic cancer: from human disease to preclinical modelling
    Jimin Min, Vasiliki Liaki, Peter Y. Yu, Carmen Guerra, Anirban Maitra · 2026 · Gut
  70. The extracellular matrix protein SNED1 affects self-renewal, proliferation and adipogenic differentiation of human adipose stem/progenitor cells
    Sonja Großmann, Petra Waldegger, Tina Rauchenwald, Werner Zwerschke · 2026 · Adipocyte